July 23, 2017 3:22 AM ET

Biotechnology

Company Overview of Adamas Pharmaceuticals, Inc.

Key Executives for Adamas Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Gregory T. Went Ph.D.27 RelationshipsCo-Founder, Chairman & Chief Executive Officer53
Alfred G. Merriweather No RelationshipsCFO & Principal Accounting Officer63
Richard A. King 15 RelationshipsChief Operating Officer52
Rajiv Patni M.D.No RelationshipsChief Medical Officer48
Jennifer J. Rhodes No RelationshipsChief Compliance Officer, Chief Business Officer, General Counsel and Corporate Secretary47

Adamas Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Gregory T. Went Ph.D. 27 RelationshipsAdamas Pharmaceuticals, Inc.53
William W. Ericson J.D. 153 RelationshipsWildcat Venture Partners58
Richard H. Booth CPA, CLU, ChFC 73 RelationshipsLimbach Holdings, Inc.70
Martha J. Demski 35 RelationshipsNeothetics, Inc.64
David L. Mahoney 43 RelationshipsSymantec Corporation63
View All Board Members

Adamas Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Martha J. Demski35 Relationships3 Executives
Compensation Committee CPA, CLU, ChFCRichard H. Booth73 Relationships3 Executives
Nominating Committee J.D.William W. Ericson153 Relationships2 Executives
Corporate Governance Committee J.D.William W. Ericson153 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$450.0K
450.0K
389.7K
Bonus$250.0K
250.0K
235.9K
Total Short Term Compensation$7.9M
Not meaningful
Total Value of Options$700.0K
700.0K
18.3M
Compensation as of Fiscal Year 2016
Adamas Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Neurocrine Biosciences Announces the Appointment of Julie Cooke as Chief People Officer
July 21, 2017 1:28 PM ET
Valens GroWorks Corp. Appoints Saul Katz as President
July 21, 2017 4:19 AM ET
Aeterna Zentaris Inc. Announces Executive Changes
July 20, 2017 9:00 PM ET
Aeglea BioTherapeutics, Inc. Announces Executive Changes
July 20, 2017 8:01 PM ET
Trevena, Inc. Announces the Resignation of David Soergel as Chief Medical Officer
July 20, 2017 7:33 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Adamas Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.